Drug Trial Radar · NCT06700148
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds
Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
840
Actual
Start
Dec 14, 2024
Primary completion
Feb 19, 2025
Study completion Jul 16, 2025
Sponsor
- Lead sponsor
- CanSino Biologics Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 7 years, up to 17 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, blinded, peer-controlled study. There will be 2 treatment groups, screened subjects were given study numbers in the order of enrollment and randomly assigned to the test and control groups in a 1:1 ratio. Subjects were required to complete a 1-dose immunization program with 0.5 ml of vaccine in both the test and control groups, afterwards some subjects entered the immune persistence group.
Conditions
- Meningococcal Meningitis
Interventions
MCV4Biological
1 dose of MCV4 on Day 0
MPSV4Biological
1 dose of MPSV4 on Day0
Primary outcomes
What the sponsor says the trial is designed to measure.
- Meningococcal Antibody Positive Conversion Rates and GMT for Groups A, C, Y, and W135 in All SubjectsTime frame: 30 Days After Immunization
- Geometric Mean Titer (GMT) for Groups A, C, Y, and W135 in All SubjectsTime frame: 30 Days after immunization
- Incidence of adverse reactions in all subjectsTime frame: Within 30 mins after immunization
- Incidence of adverse reactions/events in all subjectsTime frame: Within 7 days after immunization
- Incidence of adverse reactions/events in all subjectsTime frame: Within 30 days after immunization
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Dengfeng Center for Disease Control and Prevention
Dengfeng, China
Kaifeng Center for Disease Control and Prevention
Kaifeng, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.